HBK Investments’s Medicines Co MDCO Stock Holding History

HBK Investments’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,880,000	Closed	-$330M	–	631
2019 Q4	$330M	Buy	+3,880,000	New	+$259M	3.18%	6
2016 Q2	–	Sell	-6,600	Closed	-$210K	–	1149
2016 Q1	$210K	Buy	+6,600	New	+$216K	﹤0.01%	892
2014 Q4	–	Sell	-12,700	Closed	-$283K	–	1183
2014 Q3	$283K	Buy	+12,700	New	+$323K	﹤0.01%	852

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

HBK Investments's MDCO Position: Q1 2020 in Review

HBK Investments sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 3,880,000 shares — an estimated $330M sold.

HBK Investments first reported a position in MDCO in Q3 2014 and held it in 3 quarters. The position peaked at $330M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

HBK Investments reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
HBK Investments sold 3,880,000 Medicines Co shares in Q1 2020, an estimated $330M.
HBK Investments first reported a position in Medicines Co in Q3 2014 and held it in 3 quarters.
HBK Investments's Medicines Co position peaked at $330M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on HBK Investments's 13F filing for Q1 2020, filed 15 May 2020.